Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
95,269
Price
$1.80
Total Value
$171.48K
Shares Held After
5,185,862
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
23
Price
$197.19
Total Value
$4.54K
Shares Held After
43,187
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
381
Price
$196.36
Total Value
$74.81K
Shares Held After
43,210
% of Holdings
0.9%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
23
Price
$195.60
Total Value
$4.50K
Shares Held After
43,591
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$192.18
Total Value
$192.18
Shares Held After
43,614
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
39
Price
$191.00
Total Value
$7.45K
Shares Held After
43,615
% of Holdings
0.1%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
7,549
Price
$1.73
Total Value
$13.06K
Shares Held After
210,172
% of Holdings
3.5%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
736
Price
$46.63
Total Value
$34.32K
Shares Held After
12,965
% of Holdings
5.4%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
4,064
Price
$46.03
Total Value
$187.07K
Shares Held After
13,701
% of Holdings
22.9%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
200
Price
$44.15
Total Value
$8.83K
Shares Held After
17,765
% of Holdings
1.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
Invus Global Management, LLC — Director
Shares
1,538,462
Price
$1.30
Total Value
$2.00M
Shares Held After
1,538,462
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
100
Price
$47.23
Total Value
$4.72K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,936
Price
$46.37
Total Value
$275.27K
Shares Held After
100
% of Holdings
98.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
8,364
Price
$45.89
Total Value
$383.82K
Shares Held After
6,036
% of Holdings
58.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
600
Price
$44.20
Total Value
$26.52K
Shares Held After
14,400
% of Holdings
4.0%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
20,070
Price
$5.09
Total Value
$102.17K
Shares Held After
137,722
% of Holdings
12.7%
Absci Corp (ABSI)
Jonasson Zachariah — CFO / CBO
Shares
17,496
Price
$2.99
Total Value
$52.31K
Shares Held After
383,538
% of Holdings
4.4%
Absci Corp (ABSI)
McClain Sean — Director
Shares
26,761
Price
$2.99
Total Value
$80.02K
Shares Held After
8,334,567
% of Holdings
0.3%
Allogene Therapeutics, Inc. (ALLO)
Roberts Zachary — EVP of R&D
Shares
35,700
Price
$1.77
Total Value
$63.19K
Shares Held After
581,166
% of Holdings
5.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
5,843
Price
$42.08
Total Value
$245.90K
Shares Held After
30,167
% of Holdings
16.2%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
102,581
Price
$42.08
Total Value
$4.32M
Shares Held After
292,415
% of Holdings
26.0%
Allogene Therapeutics, Inc. (ALLO)
Yoshiyama Annie — SVP, Finance
Shares
4,167
Price
$1.72
Total Value
$7.17K
Shares Held After
130,322
% of Holdings
3.1%
Allogene Therapeutics, Inc. (ALLO)
Douglas Earl Martin — SVP, General Counsel
Shares
22,900
Price
$1.76
Total Value
$40.30K
Shares Held After
564,948
% of Holdings
3.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
15,500
Price
$14.69
Total Value
$227.62K
Shares Held After
3,363,898
% of Holdings
0.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
3,448
Price
$14.65
Total Value
$50.52K
Shares Held After
144,693
% of Holdings
2.3%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
15,500
Price
$14.68
Total Value
$227.59K
Shares Held After
3,363,965
% of Holdings
0.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
3,557
Price
$14.65
Total Value
$52.10K
Shares Held After
173,547
% of Holdings
2.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
100
Price
$58.00
Total Value
$5.80K
Shares Held After
450,944
% of Holdings
0.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
16,463
Price
$83.03
Total Value
$1.37M
Shares Held After
80,293
% of Holdings
17.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
48,626
Price
$83.03
Total Value
$4.04M
Shares Held After
80,293
% of Holdings
37.7%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
20,000
Price
$82.60
Total Value
$1.65M
Shares Held After
80,293
% of Holdings
19.9%
Fulcrum Therapeutics, Inc. (FULC)
Gould Robert J — Director
Shares
15,000
Price
$10.72
Total Value
$160.86K
Shares Held After
454,864
% of Holdings
3.2%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
83,689
Price
$1.39
Total Value
$116.33K
Shares Held After
3,297,794
% of Holdings
2.5%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
114,891
Price
$1.39
Total Value
$159.70K
Shares Held After
3,206,233
% of Holdings
3.5%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
96,065
Price
$1.39
Total Value
$133.53K
Shares Held After
3,321,124
% of Holdings
2.8%
Akebia Therapeutics, Inc. (AKBA)
Butler John P. — Director
Shares
46,660
Price
$1.39
Total Value
$64.86K
Shares Held After
3,417,189
% of Holdings
1.3%
Akebia Therapeutics, Inc. (AKBA)
Ostrowski Erik — SVP, CFO, CBO & Treasurer
Shares
34,951
Price
$1.39
Total Value
$48.58K
Shares Held After
672,635
% of Holdings
4.9%
Akebia Therapeutics, Inc. (AKBA)
Rucci Carolyn M. — SVP, Chief Legal Officer
Shares
27,544
Price
$1.39
Total Value
$38.29K
Shares Held After
588,378
% of Holdings
4.5%
Akebia Therapeutics, Inc. (AKBA)
Rucci Carolyn M. — SVP, Chief Legal Officer
Shares
25,382
Price
$1.39
Total Value
$35.28K
Shares Held After
615,922
% of Holdings
4.0%
Akebia Therapeutics, Inc. (AKBA)
Rucci Carolyn M. — SVP, Chief Legal Officer
Shares
16,846
Price
$1.39
Total Value
$23.42K
Shares Held After
641,304
% of Holdings
2.6%
Akebia Therapeutics, Inc. (AKBA)
Burke Steven Keith — SVP, Chief Medical Officer
Shares
20,701
Price
$1.39
Total Value
$28.77K
Shares Held After
948,432
% of Holdings
2.1%
Akebia Therapeutics, Inc. (AKBA)
Burke Steven Keith — SVP, Chief Medical Officer
Shares
25,375
Price
$1.39
Total Value
$35.27K
Shares Held After
969,133
% of Holdings
2.6%
Akebia Therapeutics, Inc. (AKBA)
Burke Steven Keith — SVP, Chief Medical Officer
Shares
21,582
Price
$1.39
Total Value
$30.00K
Shares Held After
994,508
% of Holdings
2.1%
Akebia Therapeutics, Inc. (AKBA)
Grund Nicholas — Chief Commercial Officer
Shares
31,244
Price
$1.39
Total Value
$43.43K
Shares Held After
561,750
% of Holdings
5.3%
Akebia Therapeutics, Inc. (AKBA)
Grund Nicholas — Chief Commercial Officer
Shares
53,585
Price
$1.39
Total Value
$74.48K
Shares Held After
592,994
% of Holdings
8.3%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
100
Price
$156.86
Total Value
$15.69K
Shares Held After
84,907
% of Holdings
0.1%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
3,042
Price
$155.46
Total Value
$472.91K
Shares Held After
85,007
% of Holdings
3.5%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
3,349
Price
$154.56
Total Value
$517.62K
Shares Held After
88,049
% of Holdings
3.7%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
928
Price
$153.16
Total Value
$142.13K
Shares Held After
91,398
% of Holdings
1.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
563
Price
$152.06
Total Value
$85.61K
Shares Held After
92,326
% of Holdings
0.6%
Showing 851–900 of 936 transactions (page 18 of 19)